OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Pharmaceutics is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Editorial Board	200
Levilactobacillus brevis surface layer protein B promotes liposome targeting to antigen-presenting cells in Peyer’s patches	136
Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites	135
Editorial Board	132
Practical use of primary drying models in an industrial environment with limited availability of equipment sensors	112
In vivo methodologies to assist preclinical development of topical fixed-dose combinations for pain management	109
Corrigendum to article “Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies” [Int. J. Pharm. 431(1–2) (2012	107
Corrigendum to “Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow” [Int. J. Pharm. 659 (2024) 124246]	98
Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization	97
Corrigendum to “Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers” [Int. J. Pharm. 604 (2021) 120755]	95
Corrigendum to “Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect” [Int. J. Pharm. 652 (2024) 123802]	93
In vivo and in vitro transdermal availability of Ibuprofen using novel solubility enhancing fluid nanosized carrier systems	93
A quantification of gastric and duodenal fluid volumes in older adults using MRI	92
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration	90
From laminar to turbulent flow in a dry powder inhaler: The effect of simple design modifications	85
A framework to optimize spring-driven autoinjectors	80
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii	79
Wet granulation end point prediction using dimensionless numbers in a mixer torque rheometer: Relationship between capillary and Weber numbers and the optimal wet mass consistency	78
Evaluation of a polymeric topical formulation of Endoxifen in an estrogen receptor positive breast cancer murine model	77
Protective role of transforming growth factor-Β3 (TGF-Β3) in the formation of radiation-induced capsular contracture around a breast implant: In vivo experimental study	77
Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)	76
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution	74
Hydrogel-forming microarray patches combined with powder-based reservoir for labetalol hydrochloride transdermal delivery	73
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine	73
Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of oral submucosal fibrosis (OSF)	72

Development of a predictive model for gravimetric powder feeding from an API-rich materials properties library	72
In situ gel-forming oil as rectally delivering platform of hydrophobic therapeutics for ulcerative colitis therapy	69
Editorial Board	68
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions	68
Editorial Board	68
DNA-templated nanosheets for enhanced chemodynamic therapy and gene therapy to inhibit tumor recurrence and metastasis	67
Exploring the relationship between bulk Young’s Modulus of materials and milling efficiency during wet bead milling of pharmaceutical compounds	66
Wharton's jelly mesenchymal stem cell-derived small extracellular vesicles as natural nanoparticles to attenuate cartilage injury via microRNA regulation	64
pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer	63
Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: Anti-hepatocellular carcinoma and reduced hepatotoxicity	62
Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis	62
Heme oxygenase 1 inhibitor discovery and formulation into nanostructured lipid carriers as potent and selective treatment against triple negative metastatic breast cancer	61
Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids	61
Lyophilization enhances the stability of Panax notoginseng total saponins-loaded transfersomes without adverse effects on ex vivo/in vivo skin permeation	61
Machine learning in additive manufacturing & Microfluidics for smarter and safer drug delivery systems	58
Inhalable FN-binding liposomes or liposome-exosome hybrid bionic vesicles encapsulated microparticles for enhanced pulmonary fibrosis therapy	58
Tablet diversion strategy based on in-line NIR tablet press feed frame measurements	55
A smart β-Cyclodextrin-Aza[5]Helicene system for enhanced gemcitabine delivery and tracking in cancer cells	55
Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer	55
Rapidly separable bubble microneedle-patch system present superior transdermal mRNA delivery efficiency	54
Biomimetic replenishment therapy of cortisol using semi-solid extrusion – 3D printed tablets for adrenal insufficiencies	54
Mast cell activators as adjuvants for intranasal mucosal vaccines	53
Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells	53
Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis	53
3D printing: Innovative solutions for patients and pharmaceutical industry	52
Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy	52
Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement	52